PALISADE BIO, INC.: 10-K filed 2019-03-22
What PALISADE BIO, INC. reported in its annual report filed 2019-03-22 (fiscal FY 2018): 35 published measures, 72 facts as tagged in accession 0001171843-19-001917.
This filing
- Form
- 10-K (annual report)
- Filed
- 2019-03-22
- Fiscal period
- fiscal FY 2018
- Accession
- 0001171843-19-001917 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 7,684,450 | USD | |
| At 2017-12-31 | 13,884,456 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 1,634,900 | USD | |
| At 2017-12-31 | 5,369,327 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 6,049,550 | USD | |
| At 2017-12-31 | 8,515,129 | USD | |
| At 2016-12-31 | 11,330,778 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 5,787,110 | USD | |
| At 2017-12-31 | 6,674,940 | USD | |
| At 2016-12-31 | 15,194,949 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | -4,924,617 | USD | 365 |
| 2017-01-01 to 2017-12-31 | -15,665,983 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | -7,692,419 | USD | 365 |
| 2017-01-01 to 2017-12-31 | -13,416,162 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 1,714 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 11,401 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 1,814,233 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 4,990,778 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 4,998,286 | USD | 365 |
| 2017-01-01 to 2017-12-31 | -94,046 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | -213,623,893 | USD | |
| At 2017-12-31 | -208,699,276 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 90,311 | USD | |
| At 2017-12-31 | 172,886 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 634,082 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 1,769,964 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | -8,259,456 | USD | 365 |
| 2017-01-01 to 2017-12-31 | -13,307,105 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 6,508,393 | USD | |
| At 2017-12-31 | 12,448,799 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 7,698 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 159,066 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 1,051,166 | USD | |
| At 2017-12-31 | 1,514,569 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 763,543 | USD | |
| At 2017-12-31 | 883,462 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 294,057 | USD | |
| At 2017-12-31 | 312,802 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 8,519,456 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 13,567,105 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 3,960,191 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 8,096,095 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 18,205,060 | shares | |
| At 2017-12-31 | 15,160,014 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 219,481,805 | USD | |
| At 2017-12-31 | 217,050,174 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | -413 | USD | |
| At 2017-12-31 | 2,631 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 992,571 | USD | |
| At 2017-12-31 | 994,811 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 902,260 | USD | |
| At 2017-12-31 | 821,925 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 763,543 | USD | |
| At 2017-12-31 | 883,462 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 23,965 | USD | |
| At 2017-12-31 | 13,853 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | -4,927,661 | USD | 365 |
| 2017-01-01 to 2017-12-31 | -15,667,257 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 4,559,265 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 5,471,010 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 84,000 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 100,000 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 102,000 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 189,000 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 3,334,839 | USD | 365 |
| 2017-01-01 to 2017-12-31 | -2,358,878 | USD | 365 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | -2,741,660 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 19,254,602 | USD | 365 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | 7,698 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 118,257 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-12-31 | -18,745 | USD | 365 |
| 2017-01-01 to 2017-12-31 | 302,311 | USD | 365 |
Inspect the source
- Entity
- PALISADE BIO, INC. / CIK 0001357459
- Captured
- 2026-09-20T07:55:46.162Z
- SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))